In 2015, an interesting study tried to elucidate the role of FAK in HCC by performing a hepatocyte-specific deletion of FAK in an oncogenic-induced mouse model of HCC obtained after c-MET and β-catenin (CAT) co-delivery [62]. Here, PTK2 is linked to hepatocellular carcinoma.